Overview
- An Italian multicenter study published in The American Journal of Gastroenterology followed 156 high‑risk people for three years with MRI and endoscopic ultrasound, finding one premalignant lesion and eight adenocarcinomas.
- Five of the eight cancers were detected during surveillance at stage I, while three were already advanced at the start of screening, and five occurred in carriers of cancer‑predisposing mutations.
- Italy records more than 14,500 new pancreatic cancer cases annually and diagnoses have climbed about 21% from roughly 12,200 in 2013 to nearly 14,800 in 2023, with mortality continuing to rise.
- There is no population‑wide screening and early symptoms are nonspecific, so only about 20% of cases are found early enough for potentially curative surgery.
- Experts cite modest therapeutic gains from improved chemotherapy and increased use of minimally invasive surgery in about one‑third of operable cases, with better outcomes when care is centralized in experienced centers and risk reduction targets smoking, obesity, diabetes and alcohol‑related chronic pancreatitis.